Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Exploration of potential genomic portraits associated with intrahepatic recurrence in human hepatocellular carcinoma.

Kittaka N, Takemasa I, Seno S, Takeda Y, Kobayashi S, Marubashi S, Dono K, Umeshita K, Nagano H, Matsuda H, Monden M, Mori M, Doki Y.

Ann Surg Oncol. 2010 Dec;17(12):3145-54. doi: 10.1245/s10434-010-1150-9. Epub 2010 Jul 13.

PMID:
20625842
2.

Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma.

Woo HG, Park ES, Cheon JH, Kim JH, Lee JS, Park BJ, Kim W, Park SC, Chung YJ, Kim BG, Yoon JH, Lee HS, Kim CY, Yi NJ, Suh KS, Lee KU, Chu IS, Roskams T, Thorgeirsson SS, Kim YJ.

Clin Cancer Res. 2008 Apr 1;14(7):2056-64. doi: 10.1158/1078-0432.CCR-07-1473.

3.
4.

Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.

Okamoto M, Utsunomiya T, Wakiyama S, Hashimoto M, Fukuzawa K, Ezaki T, Hanai T, Inoue H, Mori M.

Ann Surg Oncol. 2006 Jul;13(7):947-54. Epub 2006 May 23.

PMID:
16788756
5.

Predictive value of expression and promoter hypermethylation of XAF1 in hepatitis B virus-associated hepatocellular carcinoma treated with transplantation.

Zhang F, Wu LM, Zhou L, Chen QX, Xie HY, Feng XW, Zheng SS.

Ann Surg Oncol. 2008 Dec;15(12):3494-502. doi: 10.1245/s10434-008-0146-1. Epub 2008 Oct 2.

PMID:
18830757
6.

Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.

Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A.

Ann Surg Oncol. 2010 Mar;17(3):923-32. doi: 10.1245/s10434-009-0790-0. Epub 2009 Nov 7.

PMID:
19898900
7.

Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence.

Yi X, Luk JM, Lee NP, Peng J, Leng X, Guan XY, Lau GK, Beretta L, Fan ST.

Mol Cell Proteomics. 2008 Feb;7(2):315-25. Epub 2007 Oct 14.

8.

Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma.

Chen JD, Liu CJ, Lee PH, Chen PJ, Lai MY, Kao JH, Chen DS.

Clin Gastroenterol Hepatol. 2004 Jan;2(1):64-71.

PMID:
15017634
9.

Reduced expression of reelin (RELN) gene is associated with high recurrence rate of hepatocellular carcinoma.

Okamura Y, Nomoto S, Kanda M, Hayashi M, Nishikawa Y, Fujii T, Sugimoto H, Takeda S, Nakao A.

Ann Surg Oncol. 2011 Feb;18(2):572-9. doi: 10.1245/s10434-010-1273-z. Epub 2010 Aug 24.

PMID:
20734148
10.

Integrated analysis of prognostic gene expression profiles from hepatitis B virus-positive hepatocellular carcinoma and adjacent liver tissue.

Kim BY, Suh KS, Lee JG, Woo SR, Park IC, Park SH, Han CJ, Kim SB, Jeong SH, Yeom YI, Yang SJ, Kim CM, Cho SJ, Yoo YD, Cho MH, Jang JJ, Choi DW, Lee KH.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S328-38. doi: 10.1245/s10434-011-1709-0. Epub 2011 Apr 30.

PMID:
21533656
11.

Expression analysis of THOP1 in background liver, a prognostic predictive factor in hepatocellular carcinoma, extracted by multiarray analysis.

Nomoto S, Hishida M, Inokawa Y, Takano N, Kanda M, Nishikawa Y, Fujii T, Koike M, Sugimoto H, Kodera Y.

Ann Surg Oncol. 2014 Jun;21 Suppl 3:S443-50. doi: 10.1245/s10434-014-3581-1. Epub 2014 Mar 7.

PMID:
24604581
12.

HCV-associated hepatocellular carcinoma without cirrhosis.

el-Refaie A, Savage K, Bhattacharya S, Khakoo S, Harrison TJ, el-Batanony M, Soliman el-S, Nasr S, Mokhtar N, Amer K, Scheuer PJ, Dhillon AP.

J Hepatol. 1996 Mar;24(3):277-85.

PMID:
8778193
13.

Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression.

Okabe H, Satoh S, Kato T, Kitahara O, Yanagawa R, Yamaoka Y, Tsunoda T, Furukawa Y, Nakamura Y.

Cancer Res. 2001 Mar 1;61(5):2129-37.

14.
15.
16.
17.

The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.

Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.

J Exp Clin Cancer Res. 1999 Sep;18(3):379-89. Erratum in: J Exp Clin Cancer Res 2000 Mar;19(1):125.

PMID:
10606185
18.

Molecular prediction of early recurrence after resection of hepatocellular carcinoma.

Yoshioka S, Takemasa I, Nagano H, Kittaka N, Noda T, Wada H, Kobayashi S, Marubashi S, Takeda Y, Umeshita K, Dono K, Matsubara K, Monden M.

Eur J Cancer. 2009 Mar;45(5):881-9. doi: 10.1016/j.ejca.2008.12.019. Epub 2009 Jan 23.

PMID:
19167881
19.

Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.

Toyoda H, Kumada T, Kiriyama S, Sone Y, Tanikawa M, Hisanaga Y, Kanamori A, Yamaguchi A, Isogai M, Kaneoka Y, Washizu J.

J Gastroenterol Hepatol. 2008 Mar;23(3):459-66. Epub 2007 Sep 14.

PMID:
17854425
20.

Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.

Moribe T, Iizuka N, Miura T, Stark M, Tamatsukuri S, Ishitsuka H, Hamamoto Y, Sakamoto K, Tamesa T, Oka M.

Int J Oncol. 2008 Nov;33(5):949-58.

PMID:
18949357

Supplemental Content

Support Center